Diagnostic Giant Lumexa Set for Nasdaq Launch
Summarize this article with:
Live on Bloomberg TVDiagnostic Giant Lumexa Set for Nasdaq LaunchOpen InterestDecember 11th, 2025, 5:24 PM GMT+0000Lumexa Imaging is set to make its public debut—raising $462.5 million in its IPO. The company runs 184 diagnostic centers across 13 states and will start trading on the Nasdaq under the ticker LMRI. CEO Caitlin Zulla joined Bloomberg Open Interest to talk about the debut. (Source: Bloomberg)More From Open Interest10:28Victor Khosla Says 'We're Living Truly in a K-Shaped Economy'27 minutes ago01:15New Lilly Shot Reduces Body Weight by 23% in Study3 hours ago02:11Disney to Invest $1 Billion in OpenAI, License Characters on Sora3 hours ago01:29:17Investors Await Fed Decision | Open Interest 12/10/202523 hours agoAll episodes and clipsBloomberg TechnologyThe only daily news program focused exclusively on technology, innovation and the future of business from San Francisco. Hosted by Emily Chang.More episodes and clips44:09SpaceX Said to Pursue 2026 IPO | Bloomberg Tech 12/10/202506:13SpaceX IPO 'Seismic Event' for Space Industry: Will Whitehorn06:03More Sanguine About Paramount's Warner Bros. Bid: Needham's Martin05:08SpaceX Said to Pursue 2026 IPO, Raising Far Above $30 BillionThe David Rubenstein Show"The David Rubenstein Show: Peer-to-Peer Conversations" explores successful leadership through the personal and professional choices of the most influential people in business.More episodes and clips24:06The David Rubenstein Show: Ynon Kreiz24:05David Rubenstein Show: Kevin Hassett24:05The David Rubenstein Show: Maria Sharapova24:06The David Rubenstein Show: Justice Anthony KennedySee all shows